The TACTT team focuses on developing novel, targeted anticancer strategies that specifically eliminate tumor cells and mostly leave normal, healthy cells alone. Targeted therapy is a cancer treatment that uses drugs to target specific genes and proteins that are involved in the growth and survival of cancer cells. We are convinced that precision medicine using rationally-designed combinations of such targeted therapies may achieve this much-needed progress in cancer treatment. Moreover, we focus on oxygen deficiency (hypoxia) as a common characteristic of human solid tumours contributing to therapy resistance.
Team Leader
Associated promotors (alphabetically)
​Prof. Dr. Christophe Deben​
Prof. em. Dr. Martin Lammens
Prof. Dr. Filip Lardon
​Prof. Dr. Pierre Montay-Gruel​
Prof. em. Dr. Patrick Pauwels
Prof. Dr. Marc Peeters
Prof. Dr. Evelien Smits
Prof. em. Dr. Jan B. Vermorken
Postdoctoral researchers
Dr. Jorrit De Waele
​Dr. Hannah Zaryouh​
PhD students​
​Julie De Beukelaar​
​Jöran Melis​
​Jasper Verswyvel​
ATP
​Louize Brants​
Christophe Hermans
Hilde Lambrechts
​Ho Wa Lau​
​Dana Liu​
Céline Merlin